Immortal time bias in pharmacoepidemiology

American Journal of Epidemiology

Volumn 167, Issue 4, 2008, Pages 492-499

  Suissa, Samy ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Bias (epidemiology); Cohort studies; Databases; Epidemiologic methods; Pharmaceutical preparations; Relative biological effectiveness; Statistics; Treatment outcome

Indexed keywords

CANCER; COHORT ANALYSIS; DATABASE; EPIDEMIOLOGY; RESPIRATORY DISEASE; SURVIVAL;

COMPARATIVE STUDY; FOLLOW UP; HAZARD ASSESSMENT; HEART TRANSPLANTATION; LUNG CANCER; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PHARMACOEPIDEMIOLOGY; QUANTITATIVE ANALYSIS; REVIEW; SURVIVAL;

ALGORITHMS; ASTHMA; BIAS (EPIDEMIOLOGY); COHORT STUDIES; DATABASES AS TOPIC; EPIDEMIOLOGIC METHODS; HUMANS; LUNG NEOPLASMS; ODDS RATIO; PHARMACOEPIDEMIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 39349101029     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm324     Document Type: Review

References (40)

1. Strom BL, ed. Pharmacoepidemiology. Chichester, United Kingdom: John Wiley & Sons Ltd, 2005.
2. Ellwood PM. Shattuck lecture - outcomes management: a technology of patient experience. N Engl J Med 1988;318:1549-56.
3. Relman AS. Assessment and accountability: the third revolution in medical care. N Engl J Med 1995;319:1220-2.
4. Eptstein AM. The outcomes movement - will it get us where we want to go? N Engl J Med 1990;323:266-70.
5. Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:580-4.
6. Soriano JB, Vestbo J, Pride NB, et al. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002;20:819-25.
7. Adams RJ, Fuhlbrigge AL, Finkelstein JA, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002;109:636-42.
8. Suissa S. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 2003;168:49-53.
9. Samet JM. Measuring the effectiveness of inhaled corticosteroids for COPD is not easy! Am J Respir Crit Care Med 2003;168:1-2.
10. Suissa S. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Respir J 2004;23:391-5.
11. Suissa S, Ernst P. Bias in observational study of the effectiveness of nasal corticosteroids in asthma. J Allergy Clin Immunol 2005;115:714-19.
12. Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 2007;16:241-9.
13. Walker AM. Observation and inference: an introduction to the methods of epidemiology. Newton Lower Falls, MA: Epidemiology Resources Inc, 1991.
14. Rothman KJ, Greenland S, eds. Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1998.
15. Messmer BJ, Nora JJ, Leachman RD, et al. Survival-times after cardiac allografts. Lancet 1969;1:954-6.
16. Clark DA, Stinson EB, Griepp RB, et al. Cardiac transplantation in man. VI. Prognosis of patients selected for cardiac transplantation. Ann Intern Med 1971;75:15-21.
17. Gail MH. Does cardiac transplantation prolong life? A reassessment. Ann Intern Med 1972;76:815-17.
18. Mantel N, Byar DP. Evaluation of response-time data involving transient states: an illustration using heart-transplant data. J Am Stat Assoc 1974;69:81-6.
19. Duck BW, Carter JT, Coombes EJ.Mortality study of workers in a polyvinyl-chloride production plant. Lancet 1975;2:1197-9.
20. Wagoner JK, Infante PF, Saracci R. Vinyl chloride and mortality? Lancet 1976;2:194-5.
21. Mancuso TF, el-Attar AA. Mortality pattern in a cohort of asbestos workers. A study on employment experience. J Occup Med 1967;9:147-62.
22. Enterline PE. Pitfalls in epidemiological research. An examination of the asbestos literature. J Occup Med 1976;18:150-6.
23. Glesby MJ, Hoover DR. Survivor treatment selection bias in observational studies: examples from the AIDS literature. Ann Intern Med 1996;124:999-1005.
24. Redelmeier DA, Singh SM. Survival in Academy Award-winning actors and actresses. Ann Intern Med 2001;134:955-62.
25. Sylvestre MP, Huszti E, Hanley JA. Do OSCAR winners live longer than less successful peers? A reanalysis of the evidence. Ann Intern Med 2006;145:361-3.
26. Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-91.
27. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 2001;107:706-11.
28. Rochon PA, Tu JV, Anderson GM, et al. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet 2000;356:639-44.
29. Zhou Z, Rahme E, Abrahamowicz M, et al. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. Am J Epidemiol 2005;162:1016-23.
30. Mamdani M, Rochon P, Juurlink DN, et al. Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. Arch Intern Med 2003;163:481-6.
31. Kiri VA, Pride NB, Soriano JB, et al. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. Am J Respir Crit Care Med 2005;172:460-4.
32. Suissa S. Observational studies of inhaled corticosteroids in chronic obstructive pulmonary disease: misconstrued immortal time bias. Am J Respir Crit Care Med 2006;173:464-5.
33. Gelfand JM, Margolis DJ, Dattani H. The UK General Practice Research Database. In: Strom BL, ed. Pharmacoepidemiology. Chichester, United Kingdom: John Wiley & Sons Ltd, 2005:337-46.
34. Gail MH, Benichou J, eds. Encyclopedia of epidemiologic methods. West Sussex, United Kingdom: John Wiley & Sons Ltd, 2000. (Wiley reference series in biostatistics).
35. Szklo M, Nieto J. Epidemiology: beyond the basics. Gaithersburg, MD: Aspen Publishers Inc, 2000.
36. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma [see comments]. N Engl J Med 1992;326:501-6.
37. Suissa S, Ernst P, Benayoun B, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6.
38. Suissa S, Assimes T, Ernst P. Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction. Thorax 2003;58:43-6.
39. Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 2000;56:779-88.
40. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data 2002:1-32.